国内がん免疫療法市場レポートセラピーの種類別(モノクローナル抗体、がんワクチン、チェックポイント阻害薬、免疫調節薬、その他)、用途別(肺がん、乳がん、大腸がん、メラノーマ、前立腺がん、頭頸部がん、その他)、エンドユーザー別(病院、がん研究センター、クリニック、その他)、地域別 2025-2033

国内がん免疫療法市場レポートセラピーの種類別(モノクローナル抗体、がんワクチン、チェックポイント阻害薬、免疫調節薬、その他)、用途別(肺がん、乳がん、大腸がん、メラノーマ、前立腺がん、頭頸部がん、その他)、エンドユーザー別(病院、がん研究センター、クリニック、その他)、地域別 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A27256

Language of the Report – English

ただし、追加料金で日本語のレポートが入手できる場合もある。

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Japan Cancer Immunotherapy Market - Introduction

    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5   Japan Cancer Immunotherapy Market Landscape
    5.1    Historical and Current Market Trends (2019-2024)
    5.2    Market Forecast (2025-2033)
6   Japan Cancer Immunotherapy Market - Breakup by Therapy Type
    6.1    Monoclonal Antibodies
        6.1.1 Overview
        6.1.2 Historical and Current Market Trends (2019-2024)
        6.1.3 Market Forecast (2025-2033)
    6.2    Cancer Vaccines
        6.2.1 Overview
        6.2.2 Historical and Current Market Trends (2019-2024)
        6.2.3 Market Forecast (2025-2033)
    6.3    Checkpoint Inhibitors
        6.3.1 Overview
        6.3.2 Historical and Current Market Trends (2019-2024)
        6.3.3 Market Forecast (2025-2033)
    6.4    Immunomodulators
        6.4.1 Overview
        6.4.2 Historical and Current Market Trends (2019-2024)
        6.4.3 Market Forecast (2025-2033)
    6.5    Others
        6.5.1 Historical and Current Market Trends (2019-2024)
        6.5.2 Market Forecast (2025-2033)
7   Japan Cancer Immunotherapy Market - Breakup by Application
    7.1    Lung Cancer
        7.1.1 Overview
        7.1.2 Historical and Current Market Trends (2019-2024)
        7.1.3 Market Forecast (2025-2033)
    7.2    Breast Cancer
        7.2.1 Overview
        7.2.2 Historical and Current Market Trends (2019-2024)
        7.2.3 Market Forecast (2025-2033)
    7.3    Colorectal Cancer
        7.3.1 Overview
        7.3.2 Historical and Current Market Trends (2019-2024)
        7.3.3 Market Forecast (2025-2033)
    7.4    Melanoma
        7.4.1 Overview
        7.4.2 Historical and Current Market Trends (2019-2024)
        7.4.3 Market Forecast (2025-2033)
    7.5    Prostate Cancer
        7.5.1 Overview
        7.5.2 Historical and Current Market Trends (2019-2024)
        7.5.3 Market Forecast (2025-2033)
    7.6    Head and Neck Cancer
        7.6.1 Overview
        7.6.2 Historical and Current Market Trends (2019-2024)
        7.6.3 Market Forecast (2025-2033)
    7.7    Others
        7.7.1 Historical and Current Market Trends (2019-2024)
        7.7.2 Market Forecast (2025-2033)
8   Japan Cancer Immunotherapy Market - Breakup by End User
    8.1    Hospitals
        8.1.1 Overview
        8.1.2 Historical and Current Market Trends (2019-2024)
        8.1.3 Market Forecast (2025-2033)
    8.2    Cancer Research Centers
        8.2.1 Overview
        8.2.2 Historical and Current Market Trends (2019-2024)
        8.2.3 Market Forecast (2025-2033)
    8.3    Clinics
        8.3.1 Overview
        8.3.2 Historical and Current Market Trends (2019-2024)
        8.3.3 Market Forecast (2025-2033)
    8.4    Others
        8.4.1 Historical and Current Market Trends (2019-2024)
        8.4.2 Market Forecast (2025-2033)
9   Japan Cancer Immunotherapy Market – Breakup by Region 
    9.1    Kanto Region
        9.1.1 Overview
        9.1.2 Historical and Current Market Trends (2019-2024)
        9.1.3 Market Breakup by Therapy Type
        9.1.4 Market Breakup by Application
        9.1.5 Market Breakup by End User
        9.1.6 Key Players
        9.1.7 Market Forecast (2025-2033)
    9.2    Kansai/Kinki Region
        9.2.1 Overview
        9.2.2 Historical and Current Market Trends (2019-2024)
        9.2.3 Market Breakup by Therapy Type
        9.2.4 Market Breakup by Application
        9.2.5 Market Breakup by End User
        9.2.6 Key Players
        9.2.7 Market Forecast (2025-2033)
    9.3    Central/ Chubu Region
        9.3.1 Overview
        9.3.2 Historical and Current Market Trends (2019-2024)
        9.3.3 Market Breakup by Therapy Type
        9.3.4 Market Breakup by Application
        9.3.5 Market Breakup by End User
        9.3.6 Key Players
        9.3.7 Market Forecast (2025-2033)
    9.4    Kyushu-Okinawa Region
        9.4.1 Overview
        9.4.2 Historical and Current Market Trends (2019-2024)
        9.4.3 Market Breakup by Therapy Type
        9.4.4 Market Breakup by Application
        9.4.5 Market Breakup by End User
        9.4.6 Key Players
        9.4.7 Market Forecast (2025-2033)
    9.5    Tohoku Region
        9.5.1 Overview
        9.5.2 Historical and Current Market Trends (2019-2024)
        9.5.3 Market Breakup by Therapy Type
        9.5.4 Market Breakup by Application
        9.5.5 Market Breakup by End User
        9.5.6 Key Players
        9.5.7 Market Forecast (2025-2033)
    9.6    Chugoku Region
        9.6.1 Overview
        9.6.2 Historical and Current Market Trends (2019-2024)
        9.6.3 Market Breakup by Therapy Type
        9.6.4 Market Breakup by Application
        9.6.5 Market Breakup by End User
        9.6.6 Key Players
        9.6.7 Market Forecast (2025-2033)
    9.7    Hokkaido Region
        9.7.1 Overview
        9.7.2 Historical and Current Market Trends (2019-2024)
        9.7.3 Market Breakup by Therapy Type
        9.7.4 Market Breakup by Application
        9.7.5 Market Breakup by End User
        9.7.6 Key Players
        9.7.7 Market Forecast (2025-2033)
    9.8    Shikoku Region
        9.8.1 Overview
        9.8.2 Historical and Current Market Trends (2019-2024)
        9.8.3 Market Breakup by Therapy Type
        9.8.4 Market Breakup by Application
        9.8.5 Market Breakup by End User
        9.8.6 Key Players
        9.8.7 Market Forecast (2025-2033)
10  Japan Cancer Immunotherapy Market – Competitive Landscape
    10.1    Overview
    10.2    Market Structure
    10.3    Market Player Positioning
    10.4    Top Winning Strategies
    10.5    Competitive Dashboard
    10.6    Company Evaluation Quadrant
11  Profiles of Key Players
    11.1    Company A 
        11.1.1 Business Overview
        11.1.2 Services Offered
        11.1.3 Business Strategies
        11.1.4 SWOT Analysis
        11.1.5 Major News and Events
    11.2    Company B
        11.2.1 Business Overview
        11.2.2 Services Offered
        11.2.3 Business Strategies
        11.2.4 SWOT Analysis
        11.2.5 Major News and Events
    11.3    Company C
        11.3.1 Business Overview
        11.3.2 Services Offered
        11.3.3 Business Strategies
        11.3.4 SWOT Analysis
        11.3.5 Major News and Events
    11.4    Company D 
        11.4.1 Business Overview
        11.4.2 Services Offered
        11.4.3 Business Strategies
        11.4.4 SWOT Analysis
        11.4.5 Major News and Events
    11.5    Company E
        11.5.1 Business Overview
        11.5.2 Services Offered
        11.5.3 Business Strategies
        11.5.4 SWOT Analysis
        11.5.5 Major News and Events    
    
Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

12  Japan Cancer Immunotherapy Market - Industry Analysis
    12.1    Drivers, Restraints, and Opportunities
        12.1.1 Overview
        12.1.2 Drivers
        12.1.3 Restraints
        12.1.4 Opportunities
    12.2   Porters Five Forces Analysis
        12.2.1 Overview
        12.2.2 Bargaining Power of Buyers
        12.2.3 Bargaining Power of Suppliers
        12.2.4 Degree of Competition
        12.2.5 Threat of New Entrants
        12.2.6 Threat of Substitutes
    12.3    Value Chain Analysis
13  Appendix

国内がん免疫療法市場レポートセラピーの種類別(モノクローナル抗体、がんワクチン、チェックポイント阻害薬、免疫調節薬、その他)、用途別(肺がん、乳がん、大腸がん、メラノーマ、前立腺がん、頭頸部がん、その他)、エンドユーザー別(病院、がん研究センター、クリニック、その他)、地域別 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials